First Phase III trial of an alpha-pharmaceutical Submitted by admin on Sat, 09/24/2011 - 13:26 Read more about First Phase III trial of an alpha-pharmaceutical Source eurekalert.org Headline First Phase III trial of an alpha-pharmaceutical News Tags Bone metastases prostate cancer Alpharadin Algeta Bayer
Exelixis: Still Promising, Still Controversial Submitted by admin on Mon, 08/22/2011 - 11:47 Read more about Exelixis: Still Promising, Still Controversial Source Seeking Alpha Headline Exelixis: Still Promising, Still Controversial News Tags Exelixis cabozantinib Bone metastases
Amgen's Hopes for Prolia Go Beyond Osteoporosis Therapy Submitted by admin on Sun, 06/06/2010 - 10:57 Read more about Amgen's Hopes for Prolia Go Beyond Osteoporosis Therapy Source Seeking Alpha Headline Amgen's Hopes for Prolia Go Beyond Osteoporosis Therapy News Tags Amgen Prolia osteoporosis Bone metastases
Amgen Highlights Key Clinical Data to Be Presented at American Society of Clinical Oncology Annual Meeting Submitted by admin on Sun, 05/23/2010 - 12:07 Read more about Amgen Highlights Key Clinical Data to Be Presented at American Society of Clinical Oncology Annual Meeting Source PR-USA Headline Amgen Highlights Key Clinical Data to Be Presented at American Society of Clini… News Tags Amgen denosumab zoledronic acid Bone metastases prostate cancer
Amgen Submits Denosumab Biologics License Application to FDA for the Reduction of Skeletal Related Events in Cancer Patients Submitted by admin on Sat, 05/15/2010 - 11:51 Read more about Amgen Submits Denosumab Biologics License Application to FDA for the Reduction of Skeletal Related Events in Cancer Patients Source Amgen, PR NewsWire Headline Amgen Submits Denosumab Biologics License Application to FDA for the Reduction … News Tags Amgen denosumab Bone metastases